APA

Liu J., Prager-van der Smissen W. J. C., Look M. P., Sieuwerts A. M., Smid M., Meijer-van Gelder M. E., Foekens J. A., Hollestelle A. & Martens J. W. M. (20170213). GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease. : Cancer letters.

Chicago

Liu Jingjing, Prager-van der Smissen Wendy J C, Look Maxime P, Sieuwerts Anieta M, Smid Marcel, Meijer-van Gelder Marion E, Foekens John A, Hollestelle Antoinette and Martens John W M. 20170213. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease. : Cancer letters.

Harvard

Liu J., Prager-van der Smissen W. J. C., Look M. P., Sieuwerts A. M., Smid M., Meijer-van Gelder M. E., Foekens J. A., Hollestelle A. and Martens J. W. M. (20170213). GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease. : Cancer letters.

MLA

Liu Jingjing, Prager-van der Smissen Wendy J C, Look Maxime P, Sieuwerts Anieta M, Smid Marcel, Meijer-van Gelder Marion E, Foekens John A, Hollestelle Antoinette and Martens John W M. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease. : Cancer letters. 20170213.